The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma
Authors
Keywords
-
Journal
JOURNAL OF SURGICAL ONCOLOGY
Volume 111, Issue 5, Pages 622-631
Publisher
Wiley
Online
2015-01-08
DOI
10.1002/jso.23866
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas
- (2014) Jean-Yves Blay et al. EUROPEAN JOURNAL OF CANCER
- Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
- (2014) Ian Judson et al. LANCET ONCOLOGY
- Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: an analysis of 181 patients of the French ATU compassionate use program
- (2013) Jean-Yves Blay et al. BMC CANCER
- Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials
- (2013) A L Cesne et al. BRITISH JOURNAL OF CANCER
- External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma
- (2013) Alexia Iasonos et al. CANCER
- Localized and metastatic myxoid/round cell liposarcoma
- (2013) Aviad Hoffman et al. CANCER
- Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma
- (2013) Martee L. Hensley et al. CANCER
- Multimodality therapy for advanced or metastatic sarcoma
- (2013) Kenneth Cardona et al. CURRENT PROBLEMS IN CANCER
- Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysis
- (2013) Kashif Kalam et al. EUROPEAN JOURNAL OF CANCER
- Cisplatin: an old drug with a newfound efficacy – from mechanisms of action to cytotoxicity
- (2013) Antonio Macciò et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and safety of trabectedin as an early treatment for advanced or metastatic liposarcoma and leiomyosarcoma
- (2013) Jean Yves Blay et al. Future Oncology
- Activity of the hypoxia-activated pro-drug TH-302 in hypoxic and perivascular regions of solid tumors and its potential to enhance therapeutic effects of chemotherapy
- (2013) Jasdeep K. Saggar et al. INTERNATIONAL JOURNAL OF CANCER
- Outcome Prediction in Primary Resected Retroperitoneal Soft Tissue Sarcoma: Histology-Specific Overall Survival and Disease-Free Survival Nomograms Built on Major Sarcoma Center Data Sets
- (2013) Alessandro Gronchi et al. JOURNAL OF CLINICAL ONCOLOGY
- A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group
- (2012) P. Pautier et al. ANNALS OF ONCOLOGY
- Clinical activity of mTOR inhibition in combination with cyclophosphamide in the treatment of recurrent unresectable chondrosarcomas
- (2012) Rinat Bernstein-Molho et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma
- (2012) J. C. Brenner et al. CANCER RESEARCH
- Randomized Comparison of Intensified Six-Drug Versus Standard Three-Drug Chemotherapy for High-Risk Nonmetastatic Rhabdomyosarcoma and Other Chemotherapy-Sensitive Childhood Soft Tissue Sarcomas: Long-Term Results From the International Society of Pediatric Oncology MMT95 Study
- (2012) Odile Oberlin et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group
- (2012) Richard B. Womer et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Chemotherapy With Methotrexate, Cisplatin, and Doxorubicin With or Without Ifosfamide in Nonmetastatic Osteosarcoma of the Extremity: An Italian Sarcoma Group Trial ISG/OS-1
- (2012) Stefano Ferrari et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial
- (2012) Penella J Woll et al. LANCET ONCOLOGY
- Mitosis-targeted anti-cancer therapies: where they stand
- (2012) K-S Chan et al. Cell Death & Disease
- Metabolomics Strategy Reveals Subpopulation of Liposarcomas Sensitive to Gemcitabine Treatment
- (2012) D. Braas et al. Cancer Discovery
- Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network
- (2011) S. Stacchiotti et al. ANNALS OF ONCOLOGY
- Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma
- (2011) A. Gronchi et al. ANNALS OF ONCOLOGY
- Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor
- (2011) Min S. Park et al. CANCER
- Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas
- (2011) Antoine Italiano et al. CANCER
- Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of TH-302, a Hypoxia-Activated Prodrug, in Patients with Advanced Solid Malignancies
- (2011) G. J. Weiss et al. CLINICAL CANCER RESEARCH
- A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: A gynecologic oncology group study
- (2011) Bradley J. Monk et al. GYNECOLOGIC ONCOLOGY
- Prognostic Factors After Relapse in Nonmetastatic Rhabdomyosarcoma: A Nomogram to Better Define Patients Who Can Be Salvaged With Further Therapy
- (2011) Julia C. Chisholm et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study
- (2011) Xavier García-del-Muro et al. JOURNAL OF CLINICAL ONCOLOGY
- A Phase I Study of the Safety and Pharmacokinetics of the Hypoxia-Activated Prodrug TH-302 in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma
- (2011) Kristen N. Ganjoo et al. ONCOLOGY
- Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol
- (2010) S. Ferrari et al. ANNALS OF ONCOLOGY
- Trends in survival for patients with metastatic soft-tissue sarcoma
- (2010) Antoine Italiano et al. CANCER
- Outcomes in paediatric metastatic rhabdomyosarcoma: Results of The International Society of Paediatric Oncology (SIOP) study MMT-98
- (2010) Heather P. McDowell et al. EUROPEAN JOURNAL OF CANCER
- Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group
- (2010) Leo Mascarenhas et al. JOURNAL OF CLINICAL ONCOLOGY
- Vitamin E neuroprotection for cisplatin neuropathy: A randomized, placebo-controlled trial
- (2010) A. Pace et al. NEUROLOGY
- Extended phase I evaluation of vincristine, irinotecan, temozolomide, and antibiotic in children with refractory solid tumors
- (2010) René Y. McNall-Knapp et al. PEDIATRIC BLOOD & CANCER
- Doxorubicin pathways
- (2010) Caroline F. Thorn et al. Pharmacogenetics and Genomics
- Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy
- (2009) N. Penel et al. ANNALS OF ONCOLOGY
- FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas
- (2009) M. R. Benz et al. CLINICAL CANCER RESEARCH
- Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis
- (2009) Anastasia Constantinidou et al. EUROPEAN JOURNAL OF CANCER
- Sequential high-dose chemotherapy for children with metastatic rhabdomyosarcoma
- (2009) Gianni Bisogno et al. EUROPEAN JOURNAL OF CANCER
- Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas
- (2009) Stefan Sleijfer et al. EUROPEAN JOURNAL OF CANCER
- Adjuvant gemcitabine plus docetaxel for completely resected stages I–IV high grade uterine leiomyosarcoma: Results of a prospective study
- (2009) Martee L. Hensley et al. GYNECOLOGIC ONCOLOGY
- Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma
- (2009) Jérôme Fayette et al. INVESTIGATIONAL NEW DRUGS
- Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803
- (2009) Carola A.S. Arndt et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiinstitutional phase II study of neoadjuvant chemotherapy for osteosarcoma (NECO study) in Japan: NECO-93J and NECO-95J
- (2009) Yukihide Iwamoto et al. JOURNAL OF ORTHOPAEDIC SCIENCE
- Irinotecan and temozolomide for Ewing sarcoma: The Memorial Sloan-Kettering experience
- (2009) Denise A. Casey et al. PEDIATRIC BLOOD & CANCER
- A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma
- (2008) Nabeel Pervaiz et al. CANCER
- A Synovial Sarcoma-Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for Patients
- (2008) R. J. Canter et al. CLINICAL CANCER RESEARCH
- Paclitaxel in patients with advanced angiosarcomas of soft tissue: A retrospective study of the EORTC soft tissue and bone sarcoma group
- (2008) M. Schlemmer et al. EUROPEAN JOURNAL OF CANCER
- Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study
- (2008) Martee L. Hensley et al. GYNECOLOGIC ONCOLOGY
- Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial
- (2008) Martee L. Hensley et al. GYNECOLOGIC ONCOLOGY
- Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study
- (2008) Nicolas Penel et al. JOURNAL OF CLINICAL ONCOLOGY
- Results of the EICESS-92 Study: Two Randomized Trials of Ewing's Sarcoma Treatment—Cyclophosphamide Compared With Ifosfamide in Standard-Risk Patients and Assessment of Benefit of Etoposide Added to Standard Treatment in High-Risk Patients
- (2008) Michael Paulussen et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of results of a pilot study of alternating vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide with IRS-IV in intermediate risk rhabdomyosarcoma: A report from the Children's Oncology Group
- (2006) Carola A.S. Arndt et al. PEDIATRIC BLOOD & CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started